BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21496867)

  • 1. Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers.
    Xu HT; Yang LH; Li QC; Liu SL; Liu D; Xie XM; Wang EH
    Hum Pathol; 2011 Oct; 42(10):1491-8. PubMed ID: 21496867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
    Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
    Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage.
    Xu HT; Xie XM; Li QC; Liu SL; Dai SD; Liu Y; Wang EH
    APMIS; 2013 Feb; 121(2):111-9. PubMed ID: 23030416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression patterns and correlations of chibby, β-catenin, and DNA methyltransferase-1 and their clinicopathological significance in lung cancers.
    Xu HT; Li QC; Dai SD; Xie XM; Liu DI; Wang EH
    APMIS; 2011 Nov; 119(11):750-8. PubMed ID: 21995627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential.
    Machida Y; Ueda Y; Shimasaki M; Sato K; Sagawa M; Katsuda S; Sakuma T
    Hum Pathol; 2011 May; 42(5):669-78. PubMed ID: 21237499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIN-1 protein expression and localization in glioblastoma.
    Pećina-Slaus N; Martić TN; Kokotović T; Kusec V; Tomas D; Hrasćan R
    Coll Antropol; 2011 Jan; 35 Suppl 1():101-6. PubMed ID: 21648318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of EYA2 in non-small cell lang cancer].
    Guo JT; Ding LH; Liang CY; Zhou NK; Ye QN
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):528-31. PubMed ID: 19950702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer.
    Xu HT; Wang L; Lin D; Liu Y; Liu N; Yuan XM; Wang EH
    Am J Clin Pathol; 2006 Apr; 125(4):534-41. PubMed ID: 16627264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
    Shibahara K; Sugio K; Osaki T; Uchiumi T; Maehara Y; Kohno K; Yasumoto K; Sugimachi K; Kuwano M
    Clin Cancer Res; 2001 Oct; 7(10):3151-5. PubMed ID: 11595709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.
    Nonaka D; Fabbri A; Roz L; Mariani L; Vecchione A; Moore GW; Tavecchio L; Croce CM; Sozzi G
    Cancer Res; 2005 Feb; 65(4):1207-12. PubMed ID: 15735004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma.
    Narahashi T; Niki T; Wang T; Goto A; Matsubara D; Funata N; Fukayama M
    Histopathology; 2006 Oct; 49(4):349-57. PubMed ID: 16978197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
    Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
    Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.
    Ishii A; Suzuki M; Satomi K; Kobayashi H; Sakashita S; Kano J; Pei Y; Minami Y; Ishikawa S; Noguchi M
    Pathol Int; 2009 Sep; 59(9):623-30. PubMed ID: 19712129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of Axin and beta-catenin in non-small cell lung cancer].
    Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.